|
Aggarwal, M. and R. M. Brosh, Jr. (2009). "Hitting the bull''s eye: novel directed cancer therapy through helicase-targeted synthetic lethality." J Cell Biochem 106(5): 758-763.
Aggarwal, M., et al. (2010). "Delineation of WRN helicase function with EXO1 in the replicational stress response." DNA Repair (Amst) 9(7): 765-776.
Aggarwal, M., et al. (2011). "Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress." Proc Natl Acad Sci U S A 108(4): 1525-1530.
Arnoult, N., et al. (2009). "Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN." Genes Dev 23(24): 2915-2924.
Balasubramanian, S., et al. (2011). "Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?" Nat Rev Drug Discov 10(4): 261-275.
Barefield, C. and J. Karlseder (2012). "The BLM helicase contributes to telomere maintenance through processing of late-replicating intermediate structures." Nucleic Acids Res 40(15): 7358-7367.
Bischof, O., et al. (2001). "Regulation and localization of the Bloom syndrome protein in response to DNA damage." J Cell Biol 153(2): 367-380.
Bloom, D. (1954). "Congenital telangiectatic erythema resembling lupus erythematosus in dwarfs; probably a syndrome entity." AMA Am J Dis Child 88(6): 754-758.
Bochman, M. L., et al. (2012). "DNA secondary structures: stability and function of G-quadruplex structures." Nat Rev Genet 13(11): 770-780.
Bryant, H. E. and T. Helleday (2006). "Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair." Nucleic Acids Res 34(6): 1685-1691.
Bryant, H. E., et al. (2005). "Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase." Nature 434(7035): 913-917.
Bugaut, A. and S. Balasubramanian (2008). "A sequence-independent study of the influence of short loop lengths on the stability and topology of intramolecular DNA G-quadruplexes." Biochemistry 47(2): 689-697.
Burge, S., et al. (2006). "Quadruplex DNA: sequence, topology and structure." Nucleic Acids Res 34(19): 5402-5415.
Buseman, C. M., et al. (2012). "Is telomerase a viable target in cancer?" Mutat Res 730(1-2): 90-97.
Capra, J. A., et al. (2010). "G-quadruplex DNA sequences are evolutionarily conserved and associated with distinct genomic features in Saccharomyces cerevisiae." PLoS Comput Biol 6(7): e1000861.
Cesare, A. J. and R. R. Reddel (2010). "Alternative lengthening of telomeres: models, mechanisms and implications." Nat Rev Genet 11(5): 319-330.
Cheng, W. H., et al. (2008). "WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks." Mol Biol Cell 19(9): 3923-3933.
Cheng, W. H., et al. (2005). "Werner syndrome protein associates with gamma H2AX in a manner that depends upon Nbs1." FEBS Lett 579(6): 1350-1356.
Cheng, W. H., et al. (2004). "Linkage between Werner syndrome protein and the Mre11 complex via Nbs1." J Biol Chem 279(20): 21169-21176.
Cogoi, S. and L. E. Xodo (2006). "G-quadruplex formation within the promoter of the KRAS proto-oncogene and its effect on transcription." Nucleic Acids Res 34(9): 2536-2549.
Collins, K. and J. R. Mitchell (2002). "Telomerase in the human organism." Oncogene 21(4): 564-579.
Cooper, M. P., et al. (2000). "Ku complex interacts with and stimulates the Werner protein." Genes Dev 14(8): 907-912.
Crabbe, L., et al. (2004). "Defective telomere lagging strand synthesis in cells lacking WRN helicase activity." Science 306(5703): 1951-1953.
Croteau, D. L., et al. (2014). "Human RecQ helicases in DNA repair, recombination, and replication." Annu Rev Biochem 83: 519-552.
Curtin, N. J. (2012). "DNA repair dysregulation from cancer driver to therapeutic target." Nat Rev Cancer 12(12): 801-817.
De Cian, A., et al. (2007). "Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action." Proc Natl Acad Sci U S A 104(44): 17347-17352.
Dunham, M. A., et al. (2000). "Telomere maintenance by recombination in human cells." Nat Genet 26(4): 447-450.
Eddy, J. and N. Maizels (2006). "Gene function correlates with potential for G4 DNA formation in the human genome." Nucleic Acids Res 34(14): 3887-3896.
Ellis, N. A., et al. (1995). "The Bloom''s syndrome gene product is homologous to RecQ helicases." Cell 83(4): 655-666.
Ellis, N. A., et al. (1995). "Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells." Am J Hum Genet 57(5): 1019-1027.
Farmer, H., et al. (2005). "Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy." Nature 434(7035): 917-921.
Fernando, H., et al. (2006). "A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene." Biochemistry 45(25): 7854-7860.
Gellert, M., et al. (1962). "Helix formation by guanylic acid." Proc Natl Acad Sci U S A 48: 2013-2018.
German, J. (1993). "Bloom syndrome: a mendelian prototype of somatic mutational disease." Medicine (Baltimore) 72(6): 393-406.
German, J. (1997). "Bloom''s syndrome. XX. The first 100 cancers." Cancer Genet Cytogenet 93(1): 100-106.
Goldstein, S. (1990). "Replicative senescence: the human fibroblast comes of age." Science 249(4973): 1129-1133.
Gray, M. D., et al. (1997). "The Werner syndrome protein is a DNA helicase." Nat Genet 17(1): 100-103.
Guedin, A., et al. (2010). "How long is too long? Effects of loop size on G-quadruplex stability." Nucleic Acids Res 38(21): 7858-7868.
Hand, R. and J. German (1975). "A retarded rate of DNA chain growth in Bloom''s syndrome." Proc Natl Acad Sci U S A 72(2): 758-762.
Hardin, C. C., et al. (2000). "Thermodynamic and kinetic characterization of the dissociation and assembly of quadruplex nucleic acids." Biopolymers 56(3): 147-194.
Hazel, P., et al. (2006). "Predictive modelling of topology and loop variations in dimeric DNA quadruplex structures." Nucleic Acids Res 34(7): 2117-2127.
Hsu, Y. H. and J. J. Lin (2005). "Telomere and telomerase as targets for anti-cancer and regeneration therapies." Acta Pharmacol Sin 26(5): 513-518.
Huang, F. C., et al. (2008). "G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells." Mol Cancer Res 6(6): 955-964.
Huang, F. C., et al. (2012). "Induction of senescence in cancer cells by the G-quadruplex stabilizer, BMVC4, is independent of its telomerase inhibitory activity." Br J Pharmacol 167(2): 393-406.
Huang, S., et al. (1998). "The premature ageing syndrome protein, WRN, is a 3''-->5'' exonuclease." Nat Genet 20(2): 114-116.
Huber, M. D., et al. (2006). "A conserved G4 DNA binding domain in RecQ family helicases." J Mol Biol 358(4): 1071-1080.
Huppert, J. L. and S. Balasubramanian (2005). "Prevalence of quadruplexes in the human genome." Nucleic Acids Res 33(9): 2908-2916.
Huppert, J. L. and S. Balasubramanian (2007). "G-quadruplexes in promoters throughout the human genome." Nucleic Acids Res 35(2): 406-413.
Jaskelioff, M., et al. (2011). "Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice." Nature 469(7328): 102-106.
Kamath-Loeb, A. S., et al. (1998). "Werner syndrome protein. II. Characterization of the integral 3'' --> 5'' DNA exonuclease." J Biol Chem 273(51): 34145-34150.
Karmakar, P., et al. (2006). "BLM is an early responder to DNA double-strand breaks." Biochem Biophys Res Commun 348(1): 62-69.
Kim, N. W., et al. (1994). "Specific association of human telomerase activity with immortal cells and cancer." Science 266(5193): 2011-2015.
Lan, L., et al. (2005). "Accumulation of Werner protein at DNA double-strand breaks in human cells." J Cell Sci 118(Pt 18): 4153-4162.
Lee, J. H. and T. T. Paull (2005). "ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex." Science 308(5721): 551-554.
Levy, M. Z., et al. (1992). "Telomere end-replication problem and cell aging." J Mol Biol 225(4): 951-960.
Li, Q., et al. (2012). "Searching drug-like anti-cancer compound(s) based on G-quadruplex ligands." Curr Pharm Des 18(14): 1973-1983.
Lillard-Wetherell, K., et al. (2004). "Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2." Hum Mol Genet 13(17): 1919-1932.
London, T. B., et al. (2008). "FANCJ is a structure-specific DNA helicase associated with the maintenance of genomic G/C tracts." J Biol Chem 283(52): 36132-36139.
Machwe, A., et al. (2011). "The Werner and Bloom syndrome proteins help resolve replication blockage by converting (regressed) holliday junctions to functional replication forks." Biochemistry 50(32): 6774-6788.
Machwe, A., et al. (2006). "The Werner and Bloom syndrome proteins catalyze regression of a model replication fork." Biochemistry 45(47): 13939-13946.
Machwe, A., et al. (2004). "TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA." Oncogene 23(1): 149-156.
Makarov, V. L., et al. (1997). "Long G tails at both ends of human chromosomes suggest a C strand degradation mechanism for telomere shortening." Cell 88(5): 657-666.
Mao, F. J., et al. (2010). "The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage." Cancer Res 70(16): 6548-6555.
Mohaghegh, P., et al. (2001). "The Bloom''s and Werner''s syndrome proteins are DNA structure-specific helicases." Nucleic Acids Res 29(13): 2843-2849.
Moser, R., et al. (2012). "MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency." Mol Cancer Res 10(4): 535-545.
Muller, S., et al. (2012). "Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells." Org Biomol Chem 10(32): 6537-6546.
Murai, J., et al. (2012). "Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors." Cancer Res 72(21): 5588-5599.
Naasani, I., et al. (1998). "Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins." Biochem Biophys Res Commun 249(2): 391-396.
Nguyen, G. H., et al. (2013). "A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells." Chem Biol 20(1): 55-62.
Nimonkar, A. V., et al. (2011). "BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair." Genes Dev 25(4): 350-362.
Nimonkar, A. V., et al. (2008). "Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair." Proc Natl Acad Sci U S A 105(44): 16906-16911.
O''Sullivan, R. J. and J. Karlseder (2010). "Telomeres: protecting chromosomes against genome instability." Nat Rev Mol Cell Biol 11(3): 171-181.
Opresko, P. L., et al. (2005). "POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates." J Biol Chem 280(37): 32069-32080.
Opresko, P. L., et al. (2002). "Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases." J Biol Chem 277(43): 41110-41119.
Paeschke, K., et al. (2010). "Telomeres: structures in need of unwinding." FEBS Lett 584(17): 3760-3772.
Paeschke, K., et al. (2005). "Telomere end-binding proteins control the formation of G-quadruplex DNA structures in vivo." Nat Struct Mol Biol 12(10): 847-854.
Pascolo, E., et al. (2002). "Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate." J Biol Chem 277(18): 15566-15572.
Postberg, J., et al. (2012). "A telomerase-associated RecQ protein-like helicase resolves telomeric G-quadruplex structures during replication." Gene 497(2): 147-154.
Qin, Y. and L. H. Hurley (2008). "Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions." Biochimie 90(8): 1149-1171.
Ralf, C., et al. (2006). "The Bloom''s syndrome helicase can promote the regression of a model replication fork." J Biol Chem 281(32): 22839-22846.
Reddel, R. R. (2003). "Alternative lengthening of telomeres, telomerase, and cancer." Cancer Lett 194(2): 155-162.
Reddy, S., et al. (2010). "Processing of human telomeres by the Werner syndrome protein." Cell Cycle 9(16): 3137-3138.
Rezler, E. M., et al. (2005). "Telomestatin and diseleno sapphyrin bind selectively to two different forms of the human telomeric G-quadruplex structure." J Am Chem Soc 127(26): 9439-9447.
Riou, J. F., et al. (2002). "Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands." Proc Natl Acad Sci U S A 99(5): 2672-2677.
Rizzo, A., et al. (2009). "Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway." Nucleic Acids Res 37(16): 5353-5364.
Rodriguez, R., et al. (2008). "A novel small molecule that alters shelterin integrity and triggers a DNA-damage response at telomeres." J Am Chem Soc 130(47): 15758-15759.
Salvati, E., et al. (2007). "Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect." J Clin Invest 117(11): 3236-3247.
Samanta, S. and P. Karmakar (2012). "Recruitment of HRDC domain of WRN and BLM to the sites of DNA damage induced by mitomycin C and methyl methanesulfonate." Cell Biol Int 36(10): 873-881.
Sanders, C. M. (2010). "Human Pif1 helicase is a G-quadruplex DNA-binding protein with G-quadruplex DNA-unwinding activity." Biochem J 430(1): 119-128.
Shammas, M. A., et al. (2004). "Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma." Clin Cancer Res 10(2): 770-776.
Shay, J. W. and S. Bacchetti (1997). "A survey of telomerase activity in human cancer." Eur J Cancer 33(5): 787-791.
Sidorova, J. M., et al. (2013). "Distinct functions of human RECQ helicases WRN and BLM in replication fork recovery and progression after hydroxyurea-induced stalling." DNA Repair (Amst) 12(2): 128-139.
Sidorova, J. M., et al. (2008). "The RecQ helicase WRN is required for normal replication fork progression after DNA damage or replication fork arrest." Cell Cycle 7(6): 796-807.
Stewart, S. A. and R. A. Weinberg (2006). "Telomeres: cancer to human aging." Annu Rev Cell Dev Biol 22: 531-557.
Stiff, T., et al. (2006). "ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling." EMBO J 25(24): 5775-5782.
Sun, H., et al. (1998). "The Bloom''s syndrome helicase unwinds G4 DNA." J Biol Chem 273(42): 27587-27592.
Tauchi, T., et al. (2006). "Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia." Oncogene 25(42): 5719-5725.
Tejera, A. M., et al. (2001). "Chronic in vitro exposure to 3''-azido-2'', 3''-dideoxythymidine induces senescence and apoptosis and reduces tumorigenicity of metastatic mouse mammary tumor cells." Breast Cancer Res Treat 65(2): 93-99.
Todd, A. K., et al. (2007). "Sequence occurrence and structural uniqueness of a G-quadruplex in the human c-kit promoter." Nucleic Acids Res 35(17): 5799-5808.
Wang, Q., et al. (2011). "G-quadruplex formation at the 3'' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase." Nucleic Acids Res 39(14): 6229-6237.
Williamson, J. R., et al. (1989). "Monovalent cation-induced structure of telomeric DNA: the G-quartet model." Cell 59(5): 871-880.
Yang, D. and L. H. Hurley (2006). "Structure of the biologically relevant G-quadruplex in the c-MYC promoter." Nucleosides Nucleotides Nucleic Acids 25(8): 951-968.
Yu, C. E., et al. (1996). "Positional cloning of the Werner''s syndrome gene." Science 272(5259): 258-262.
Zahler, A. M., et al. (1991). "Inhibition of telomerase by G-quartet DNA structures." Nature 350(6320): 718-720.
Zakian, V. A. (1995). "Telomeres: beginning to understand the end." Science 270(5242): 1601-1607.
|